Balchem Corp
BCPC
View Detailed Chart
156.300USD
-2.420-1.52%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
5.06BMarket Cap
33.90P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.52%
5 Days
+0.21%
1 Month
+2.34%
6 Months
+0.19%
Year to Date
-4.11%
1 Year
-5.55%
View Detailed Chart
TradingKey Stock Score of Balchem Corp
Currency: USD Updated: 2025-12-19Key Insights
Balchem Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 12/70 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 191.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Balchem Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
3
analysts
Buy
Current Rating
191.000
Target Price
+29.61%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Balchem Corp Highlights
StrengthsRisks
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 953.68M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.16%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.16%.
Undervalued
The company’s latest PB is 3.90, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 30.08M shares, increasing 0.06% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 188.00 shares of this stock.
Balchem Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Balchem Corp Info
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Ticker SymbolBCPC
CompanyBalchem Corp
CEOHarris (Theodore L)
Website
FAQs
What is the current price of Balchem Corp (BCPC)?
The current price of Balchem Corp (BCPC) is 156.300.
What is the symbol of Balchem Corp?
The ticker symbol of Balchem Corp is BCPC.
What is the 52-week high of Balchem Corp?
The 52-week high of Balchem Corp is 177.400.
What is the 52-week low of Balchem Corp?
The 52-week low of Balchem Corp is 139.170.
What is the market capitalization of Balchem Corp?
The market capitalization of Balchem Corp is 5.06B.
What is the net income of Balchem Corp?
The net income of Balchem Corp is 128.47M.
Is Balchem Corp (BCPC) currently rated as Buy, Hold, or Sell?
According to analysts, Balchem Corp (BCPC) has an overall rating of Buy, with a price target of 191.000.
What is the Earnings Per Share (EPS TTM) of Balchem Corp (BCPC)?
The Earnings Per Share (EPS TTM) of Balchem Corp (BCPC) is 4.610.
Related Instruments
+0.58%
-1.38%
+0.25%
-1.55%
-1.00%
+1.04%
-0.23%
+3.81%
+1.04%
+0.09%
-1.83%
+0.50%
+1.54%
-3.10%
+3.64%
-0.69%
-0.94%
+0.19%
+0.25%
+0.81%
